Pharmacological investigations on current and new drugs for treatment of human African trypanosomiasis [PDF]
Trypanosomiasis remains a major threat to humans in sub-Saharan Africa with 55-60 million people in 36 countries at risk of infection with T.b. gambiense or T.b. rhodesiense.
Keiser, Jennifer
core +1 more source
Tsetse flies are the cyclical vector of human and animal African trypanosomiasis. To improve vector control in order to achieve the elimination of human African trypanosomiasis (HAT) and boost the control of animal diseases, investigations have been ...
Kanté Tagueu Sartrien +3 more
doaj +1 more source
The World Health Organisation has set the goal for elimination of Human African Trypanosomiasis (HAT), caused by Trypanosoma brucei gambiense (gHAT), as a public health problem for 2020 and for the total interruption of transmission to humans for 2030 ...
D. Mehlitz, D.H. Molyneux
doaj +1 more source
BackgroundThe chronic form of human African trypanosomiasis (HAT) caused by Trypanosoma brucei gambiense and commonly referred to as gambiense-HAT (gHAT) is endemic in 7 of Angola's 18 provinces.
Johnson O Ouma +7 more
doaj +1 more source
Deux projets régionaux de la FAO pour le développement de l'élevage dans les zones infestées par les glossines [PDF]
Two FAO regional projects for livestock development in the tse-tse infested areas. In this paper, the authors present the objectives, activities, countries involved and inputs of two FAO Regional projects related to livestock development in tsetse ...
Hoste, C., Toure, SM.
doaj
Programme for the Control of African Animal Trypanosomiasis and Related Development [PDF]
Council of Ministers Forty-Second Ordinary Session 10 -16 July, 1985 Addis Ababa, EthiopiaThis report discusses the programme for the control of tsetse and trypanosomiasis, as part of the mandate received by the OAU in the Lagos Plan of Action to ...
Organization of African Unity
core +1 more source
Evaluating Paratransgenesis as a Potential Control Strategy for African Trypanosomiasis [PDF]
Genetic-modification strategies are currently being developed to reduce the transmission of vector-borne diseases, including African trypanosomiasis. For tsetse, the vector of African trypanosomiasis, a paratransgenic strategy is being considered: this ...
Aksoy, Serap +4 more
core +2 more sources
Computer-aided identification of Trypanosoma brucei uridine diphosphate galactose 4'-epimerase inhibitors : toward the development of novel therapies for African sleeping sickness [PDF]
Trypanosoma brucei, the causative agent of human African trypanosomiasis, affects tens of thousands of sub-Saharan Africans. As current therapeutics are inadequate due to toxic side effects, drug resistance, and limited effectiveness, novel therapies are
Durrant, Jacob D. +3 more
core
Reproductive Impacts of African Animal Trypanosomiasis in West African Dwarf Goats-Mechanistic Insights into Trypanotolerance Survival-Fertility Trade-Off: A Systematic Review. [PDF]
Njoga UJ +4 more
europepmc +1 more source
Managing African animal trypanosomiasis in Benin: Knowledge, attitudes, and practices of cattle owners in the West Atacora zone. [PDF]
Akpo Y +3 more
europepmc +1 more source

